Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Akesobio Australia Pty Ltd
Scientific Title
A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer